Bridging Genomics to Cardiology Clinical Practice: Artificial Intelligence in Optimizing Polygenic Risk Scores: A Systematic Review [0.03%]
从基因组学过渡到心脏病临床实践：利用人工智能优化多基因风险评分的系统性研究
Kaveh Hosseini,Nazanin Anaraki,Parham Dastjerdi et al.
Kaveh Hosseini et al.
Despite advances in cardiovascular disease risk stratification, traditional risk prediction models often fail to identify high-risk individuals before adverse events occur, underscoring the need for more precise tools. Polygenic risk scores...
Advancing Preventive Cardiology: Innovations, Care Pathways, Global Challenges, and the Future of Cardiovascular Health Across the Life Course [0.03%]
预防心脏病学的发展：创新、诊疗路径、全球挑战及全生命周期心血管健康展望
Garima Sharma,Jared A Spitz,Anurag Mehta et al.
Garima Sharma et al.
Gestational Diabetes Mellitus and Heart Failure: A Systematic Review and Meta-Analysis [0.03%]
妊娠糖尿病与心力衰竭：系统评价和荟萃分析
Eric K Broni,Sebhat Erqou,Ravi Retnakaran et al.
Eric K Broni et al.
Background: The extent of the association between gestational diabetes mellitus (GDM) and the incidence of heart failure (HF) largely remains unclear. Obj...
The Effect of 12-Week e-Cigarette Use on Smoking Abstinence at 1 Year: The E3 Trial [0.03%]
12周电子烟使用对吸烟戒断一年的影响：E3试验
Kristian B Filion,Tetiana Zolotarova,Andréa Hébert-Losier et al.
Kristian B Filion et al.
Background: The current evidence regarding the long-term efficacy of electronic cigarettes (e-cigarettes) for smoking cessation is unclear. Objectives: ...
Changes in Frailty and Cardiometabolic Disease: Evidence From a Longitudinal Cohort Study and Genetic Analysis [0.03%]
基于纵向队列研究和遗传学分析探讨脆弱性和心血管代谢性疾病的关联
Wenjie Wang,Kexin Wang,Guangyuan Chen et al.
Wenjie Wang et al.
Background: Cardiometabolic diseases (CMD) include coronary heart disease, stroke, and diabetes. Patients who have ≥2 CMD are defined as cardiometabolic multimorbidity (CMM). CMD and CMM have been associated with frailty...
Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF [0.03%]
达格列净与HFrEF患者的心肾结局和载脂蛋白M水平的关系：DEFINE-HF研究的新认识
Andrew J Sauer,Joycie Chang,Zhuxuan Fu et al.
Andrew J Sauer et al.
Background: Apolipoprotein M (ApoM) is associated with lower mortality in heart failure (HF) patients and protects against cardiac and kidney injury in mice. ...
Historical Redlining and Cardio-Kidney-Metabolic Disease Risk Factors, Prevalence, and Outcomes: A Scoping Review [0.03%]
历史红标线与心血管-肾脏-代谢病的风险因素、患病率和结果：综述型研究
Ramzi Ibrahim,Dwani Patel,Hoang Nhat Pham et al.
Ramzi Ibrahim et al.
Background: Cardio-kidney-metabolic (CKM) diseases impact a large portion of the U.S. population each year, particularly among racial minorities and socially disadvantaged groups. Social factors contribute to this dispari...
Prevalence and Mortality Association of Different Stages of Cardiovascular-Kidney-Metabolic Syndrome [0.03%]
心血管-肾脏-代谢综合征不同阶段的流行率和死亡率关联性研究
Yongming Chen,Xiaoying Wu,Tianxin Long et al.
Yongming Chen et al.
Background: The cardiovascular-kidney-metabolic (CKM) syndrome, introduced by the American Heart Association, underscores the interplay among metabolic, renal, and cardiovascular dysfunctions. ...
Sociodemographic Disparities in Obesity Prevalence Among Adults Aged 20-59 Years Between 2017 and 2023 [0.03%]
2017至2023年我国20-59岁成人超重流行率的社会人口学差异分析
Olayinka J Agboola,Ryan P Chang,Madelyn Hurwitz et al.
Olayinka J Agboola et al.
Lipoprotein(a), High-Sensitivity C-Reactive Protein, and All-Cause Mortality in a Primary Prevention Cohort [0.03%]
初诊队列中载脂蛋白(a)、高敏C反应蛋白与全因死亡率的关系研究
Vincent Chen,Danielle Brennan,Madlaina Costa-Scharplatz et al.
Vincent Chen et al.